Global Gene Therapy Clinical Trial Services Market Growth Prospects and Strategic Opportunities Through 2029
Uncover key drivers, emerging technologies, and competitive movements shaping the gene therapy clinical trial services market from 2025–2034 with trusted insights from The Business Research Company
What CAGR And Valuation Are Anticipated For The Gene Therapy Clinical Trial Services Market?
The gene therapy clinical trial services market size has witnessed rapid growth in recent years. This market is set to expand from $1.53 billion in 2024 to $1.82 billion in 2025, showing a compound annual growth rate (CAGR) of 19.6%. The historical growth can be linked to several factors, including increased investment in research and development, a rising incidence of rare genetic disorders, the growing embrace of precision medicine approaches, increased regulatory support through accelerated approval pathways, and an increasing number of gene therapy candidates.
The gene therapy clinical trial services market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $3.69 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 19.2%. This anticipated growth during the forecast period can be primarily ascribed to several factors, including increasing technological progress in gene-editing tools, an expanding volume of clinical trials, an escalating need for personalized treatments, heightened investment in the manufacturing infrastructure for cell and gene therapies, and enhanced initiatives for patient recruitment. Key developments expected within the forecast timeframe encompass improvements in gene-editing technologies, progress in vector manufacturing capabilities, refined patient recruitment approaches, the incorporation of real-world evidence, and the adoption of a decentralized trial model.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27292&type=smp
What Core Drivers Are Expected To Influence The Gene Therapy Clinical Trial Services Market?
The escalating need for personalized medicine is projected to stimulate the growth of the gene therapy clinical trial services market moving forward. Personalized medicine represents an approach that tailors medical interventions to specific individual traits, such as genetic predispositions, biomarker indicators, and lifestyle aspects. The increased desire for personalized medicine is attributable to advancements in genomics and biotechnology, which enable more precise targeting of therapies. Gene therapy clinical trial services support personalized medicine by analyzing patient-specific genetic profiles and tailoring treatments accordingly, utilizing biomarker analysis and companion diagnostics to optimize therapy for each person while enhancing both safety and effectiveness. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and health care organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, a rise from six in 2022. Therefore, the expanding demand for personalized medicine is propelling the growth of the gene therapy clinical trial services market.
What Are The Main Segment Classifications In The Gene Therapy Clinical Trial Services Market?
The gene therapy clinical trial services market covered in this report is segmented
1) By Type: Clinical Trial Design And Planning, Supply And Logistics Services, Regulatory Services, Data Management And Biostatistics, Site Management And Monitoring, Other Types
2) By Application: Oncology, Hematology, Endocrine or Metabolic Disorders, Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Applications
3) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic Institutions, Government Research Institutes, Contract Research Organizations (CROs)
Subsegments:
1) By Clinical Trial Design And Planning: Protocol Development, Feasibility Studies, Patient Recruitment Strategy Design
2) By Supply And Logistics Services: Cold Chain Management, Investigational Product Packaging And Labeling, Controlled-Temperature Storage
3) By Regulatory Services: Regulatory Consulting And Strategy, Ethics Committee Submissions, Regulatory Compliance Monitoring
4) By Data Management And Biostatistics: Clinical Data Capture And Database Design, Data Validation And Quality Control, Statistical Analysis And Modeling
5) By Site Management And Monitoring: Site Selection And Qualification, Investigator Training And Support, On-Site Monitoring Visits
6) By Other Types: Pharmacovigilance And Safety Reporting, Quality Assurance And Auditing, Patient Engagement And Retention
How Are Industry Trends Steering The Expansion Of The Gene Therapy Clinical Trial Services Market?
Leading companies within the gene therapy clinical trial services market are concentrating on developing innovative solutions, such as the long-term follow-up (LTFU) model for cell and gene therapy (CGT) trials, to accelerate the overall trial process while maintaining regulatory compliance and safety standards. An LTFU model for CGT trials is a structured framework designed to monitor patients for an extended period, frequently up to 15 years after receiving CGT treatment. For instance, in May 2025, Medable Inc., a US-based SaaS company, introduced a digital-first Long-Term Follow-Up (LTFU) model specifically tailored for cell and gene therapy (CGT) trials. This model supports cell and gene therapy trials by reducing the burden on patients and sites while ensuring scientific rigor over the 15-year monitoring period required by the FDA. It improves patient access, retention, and data continuity through remote and hybrid follow-up methods, thereby enhancing long-term safety and efficacy monitoring.
Which Companies Are Contributing Significantly To The Gene Therapy Clinical Trial Services Market Growth?
Major companies operating in the gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, Labcorp, Pharmaceutical Product Development LLC, ICON plc, Syneos Health Inc., WuXi AppTec, Franklin Biolabs, Catalent Inc., Charles River Laboratories International Inc., Parexel International (MA) Corporation, Medpace Holdings Inc., Precision Medicine Group LLC, Worldwide Clinical Trials, IQVIA Holdings Inc., TFS HealthScience, Poseida Therapeutics Inc., Veristat LLC, Genprex Inc., Novotech Health Holdings Pte Limited, bluebird bio Inc.
Access The Complete Report Here:
Which Region Holds The Greatest Opportunity For Gene Therapy Clinical Trial Services Market Expansion?
North America was the largest region in the gene therapy clinical trial services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=27292&type=smp
Browse Through More Reports Similar to the Global Gene Therapy Clinical Trial Services Market 2025, By The Business Research Company
Takaful Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/takaful-global-market-report
Triazole Fungicides Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/triazole-fungicides-global-market-report
Ranibizumab Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ranibizumab-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
